The University of Chicago Header Logo

Connection

Thinle Chodon to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Thinle Chodon has written about Antibodies, Monoclonal.
Thinle Chodon
Connection Strength
0.554
Antibodies, Monoclonal
  1. Active Immunotherapy of Cancer. Immunol Invest. 2015; 44(8):817-36.
    View in: PubMed
    Score: 0.327
  2. CTLA4 blockade broadens the peripheral T-cell receptor repertoire. Clin Cancer Res. 2014 May 01; 20(9):2424-32.
    View in: PubMed
    Score: 0.077
  3. Natural killer T cells in advanced melanoma patients treated with tremelimumab. PLoS One. 2013; 8(10):e76829.
    View in: PubMed
    Score: 0.075
  4. Modulation of cell signaling networks after CTLA4 blockade in patients with metastatic melanoma. PLoS One. 2010 Sep 15; 5(9):e12711.
    View in: PubMed
    Score: 0.061
  5. CTLA4 blockade increases Th17 cells in patients with metastatic melanoma. J Transl Med. 2009 May 20; 7:35.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.